The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: Comparison with the renin-angiotensin system and the sympathetic nervous system
Open accessAbstract
Ten patients with advanced congestive heart failure were treated with an arginine vasopressin V1 antagonist during hemodynamic monitoring to determine the contribution of vasopressin to vasoconstriction in this disorder. The vasopressin antagonist caused a decrease in systemic vascular resistance in the three patients whose plasma vasopressin was greater than 4.0 pg/ml (average for the group was 2.4 +/- 0.6). Plasma vasopressin concentration correlated with the percent decrease of systemic vascular resistance (r = 0.70, p less than 0.025), serum sodium (r = 0.72, p less than 0.02) and serum creatinine (r = 0.85, p less than 0.005). To compare the relative roles of vasopressin, the renin-angiotensin system and the sympathetic nervous system, these patients also received captopril and phentolamine. Captopril decreased systemic vascular resistance by 20% (p less than 0.05), mostly in patients with high plasma renin activity. Levels of plasma renin activity ranged between 1 and 46 ng/ml per h (average 14.7 +/- 5.7) and correlated with serum sodium (r = 0.77, p less than 0.025), serum creatinine (r = 0.73, p less than 0.025) and right atrial pressure (r = 0.67, p less than 0.05). Phentolamine decreased systemic vascular resistance in all patients (average 34%, p less than 0.01), but the decrease did not correlate with the pretreatment norepinephrine concentration. Norepinephrine levels were elevated in all patients (694 +/- 110 pg/ml) and correlated with baseline stroke volume index (r = 0.75, p less than 0.025) and plasma renin activity (r = 0.67, p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antidiuretic hormone in congestive heart failure.
Riegger, G. A. J., Liebau, G., & Kochsiek, K. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90576-9 · Cited by 193
Cited by
Konstam, M. A. (2007) · JAMA · doi:10.1001/jama.297.12.1319 · Cited by 1,628
Schrier, R. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810273191705 · Cited by 497
Plasma endothelin in chronic heart failure.
McMurray, J. J., Ray, S. G., Abdullah, I., Dargie, H. J., & Morton, J. J. (1992) · Circulation · doi:10.1161/01.cir.85.4.1374 · Cited by 486
Pathophysiology of chronic heart failure
Packer, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)90405-r · Cited by 473
Udelson, J. E., Smith, W. B., Hendrix, G. H., Painchaud, C. A., Ghazzi, M., Thomas, I., Ghali, J. K., Selaru, P., Chanoine, F., Pressler, M. L., et al. (2001) · Circulation · doi:10.1161/hc4501.099313 · Cited by 362
Metadata
- Authors
- Creager, M. A., Faxon, D. P., Cutler, S. S., Kohlmann, O., Ryan, T. J., & Gavras, H.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 1986-04
- Volume
- 7
- Issue
- 4
- Pages
- 758-765
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2032943519
- Cited by
- 193
- References
- 1
- FWCI
- 16.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: Comparison with the renin-angiotensin system and the sympathetic nervous system. https://app.cochat.ai/papers/10.1016/s0735-1097(86)80333-3
- The paper
- Creager, M. A., Faxon, D. P., Cutler, S. S., Kohlmann, O., Ryan, T. J., & Gavras, H. (1986). Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: Comparison with the renin-angiotensin system and the sympathetic nervous system. Journal of the American College of Cardiology. https://doi.org/10.1016/s0735-1097(86)80333-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.